Therapeutic or prophylactic agent for immunodeficiency virus infection
AssigneeIdac Theranostics, Inc.
InventorsSatoru ITO, Shoji YOKOCHI
Life of this patent
Estimating the term…
Loading patent…
AssigneeIdac Theranostics, Inc.
InventorsSatoru ITO, Shoji YOKOCHI
Estimating the term…
Disclosed is a novel means that enables complete cure of not only acute and chronic virus infections, but also latent retrovirus infections in which incorporation of the virus into the host chromosome has occurred. In the present invention, by destroying cells containing molecules that act as scaffolds for the virus infection in the patient's body, cells per se that have been already infected with virus are destroyed while inhibiting expansion of the virus infection in the patient's body, so that final complete cure of virus infection can be realized. The treatment of immunodeficiency virus infection may be carried out by administering an antibody or the like having high cytotoxic activity to the patient to destroy at least any of CD4 molecule-containing cells, CCR5 molecule-containing cells, and CXCR4 molecule-containing cells, preferably CD4 molecule-containing cells.
A therapeutic or prophylactic agent for immunodeficiency virus infection, comprising as an effective ingredient a substance that destroys at least any of CD4 molecule-containing cells, CCR5 molecule-containing cells, and CXCR4 molecule-containing cells.
A method for treatment or prevention of virus infection in a subject, said method comprising destroying cells which are present in the body of said subject and contain a molecule that acts as a scaffold for the virus infection.
Dependencies are inferred from the claim text.